396 related articles for article (PubMed ID: 22508651)
1. Erythropoietin and erythropoiesis stimulating agents.
Debeljak N; Sytkowski AJ
Drug Test Anal; 2012 Nov; 4(11):805-12. PubMed ID: 22508651
[TBL] [Abstract][Full Text] [Related]
2. Erythropoiesis stimulating agents and techniques: a challenge for doping analysts.
Jelkmann W
Curr Med Chem; 2009; 16(10):1236-47. PubMed ID: 19355882
[TBL] [Abstract][Full Text] [Related]
3. Erythropoiesis-stimulating agents: development, detection and dangers.
Franz SE
Drug Test Anal; 2009 Jun; 1(6):245-9. PubMed ID: 20355203
[TBL] [Abstract][Full Text] [Related]
4. [Recent advances in the detection of recombinant human erythropoiesis and its analogs in doping control].
Yang X; Pang N; Liao Y; Liu H
Se Pu; 2008 Jul; 26(4):413-6. PubMed ID: 18959234
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of AMGEN clone 9G8A anti-Epo antibody for application in doping control.
Reichel C; Benetka W; Lorenc B; Thevis M
Drug Test Anal; 2016 Nov; 8(11-12):1131-1137. PubMed ID: 27552163
[TBL] [Abstract][Full Text] [Related]
6. Targeting EPO and EPO receptor pathways in anemia and dysregulated erythropoiesis.
Rainville N; Jachimowicz E; Wojchowski DM
Expert Opin Ther Targets; 2016; 20(3):287-301. PubMed ID: 26419263
[TBL] [Abstract][Full Text] [Related]
7. Erythropoietin mimetic peptides and erythropoietin fusion proteins for treating anemia of chronic kidney disease.
Gupta N; Wish JB
Curr Opin Nephrol Hypertens; 2018 Sep; 27(5):345-350. PubMed ID: 29746307
[TBL] [Abstract][Full Text] [Related]
8. Erythropoietin and analogs.
Reichel C; Gmeiner G
Handb Exp Pharmacol; 2010; (195):251-94. PubMed ID: 20020369
[TBL] [Abstract][Full Text] [Related]
9. Detection of erythropoiesis-stimulating agents in human anti-doping control: past, present and future.
Leuenberger N; Reichel C; Lasne F
Bioanalysis; 2012 Jul; 4(13):1565-75. PubMed ID: 22831473
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietins: a common mechanism of action.
Elliott S; Pham E; Macdougall IC
Exp Hematol; 2008 Dec; 36(12):1573-84. PubMed ID: 18922615
[TBL] [Abstract][Full Text] [Related]
11. Doping control analysis of recombinant human erythropoietin, darbepoetin alfa and methoxy polyethylene glycol-epoetin beta in equine plasma by nano-liquid chromatography-tandem mass spectrometry.
Yu NH; Ho EN; Wan TS; Wong AS
Anal Bioanal Chem; 2010 Apr; 396(7):2513-21. PubMed ID: 20148243
[TBL] [Abstract][Full Text] [Related]
12. Erythropoietin: new approaches to improved molecular designs and therapeutic alternatives.
Debeljak N; Sytkowski AJ
Curr Pharm Des; 2008; 14(13):1302-10. PubMed ID: 18537654
[TBL] [Abstract][Full Text] [Related]
13. Detection of DNA-recombinant human epoetin-alfa as a pharmacological ergogenic aid.
Wilber RL
Sports Med; 2002; 32(2):125-42. PubMed ID: 11817997
[TBL] [Abstract][Full Text] [Related]
14. Prolonged Duration of Erythropoiesis-Stimulating Agents' Action Delays Disease Progression in Anti-Thy 1 Antibody-Induced Chronic Glomerulonephritis Rats.
Kawasaki R; Tashiro Y; Yogo K; Serizawa K; Aizawa K; Endo K; Hirata M
Pharmacology; 2021; 106(1-2):45-52. PubMed ID: 32829322
[TBL] [Abstract][Full Text] [Related]
15. Recombinant erythropoietin and analogues: a challenge for doping control.
Pascual JA; Belalcazar V; de Bolos C; Gutiérrez R; Llop E; Segura J
Ther Drug Monit; 2004 Apr; 26(2):175-9. PubMed ID: 15228161
[TBL] [Abstract][Full Text] [Related]
16. Fc-fragment removal allows the EPO-Fc fusion protein to be detected in blood samples by IEF-PAGE.
Postnikov P; Krotov G; Mesonzhnik N; Efimova Y; Rodchenkov G
Drug Test Anal; 2015; 7(11-12):999-1008. PubMed ID: 26695487
[TBL] [Abstract][Full Text] [Related]
17. Discrimination of recombinant and endogenous urinary erythropoietin by calculating relative mobility values from SDS gels.
Kohler M; Ayotte C; Desharnais P; Flenker U; Lüdke S; Thevis M; Völker-Schänzer E; Schänzer W
Int J Sports Med; 2008 Jan; 29(1):1-6. PubMed ID: 18050057
[TBL] [Abstract][Full Text] [Related]
18. The analytical approach for detection of carbamylated erythropoietin for doping control purposes.
Kaliszewski P; Siek P; Zalewska Z; Michalak D; Kwiatkowska D
Drug Test Anal; 2020 Nov; 12(11-12):1599-1604. PubMed ID: 33119952
[TBL] [Abstract][Full Text] [Related]
19. Recent developments in doping testing for erythropoietin.
Reichel C
Anal Bioanal Chem; 2011 Aug; 401(2):463-81. PubMed ID: 21637931
[TBL] [Abstract][Full Text] [Related]
20. Sports drug testing for erythropoiesis-stimulating agents and autologous blood transfusion.
Reichel C
Drug Test Anal; 2012 Nov; 4(11):803-4. PubMed ID: 22927317
[No Abstract] [Full Text] [Related]
[Next] [New Search]
